Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or Maryland for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to Maryland only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. Maryland (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

Matthew Speicher (NPI 1275536963)

Field	Value
Entity Type	Individual
Organization	Matthew Speicher
Address	6115 Falls Rd
City	Baltimore
State	MD
ZIP	21209
Taxonomy	Ophthalmology Physician
NPI Enumerated	May 27, 2005

Payer Source	Total Paid
Medicare	$3.7M
Medicaid	$0

Key Findings

This provider is effectively single‑payer in the dataset: total Medicare revenue is $3.7M while there is no Medicaid billing on file. That concentration means analyses of this provider’s volumes and financial performance should be interpreted as Medicare‑driven rather than balanced across payers.

Revenue is highly concentrated in a small set of services: the top three Medicare codes account for 71.5% of total Medicare revenue, led by J0178 ($2.1M, 56.2%), followed by J2778 ($307.1K, 8.3%) and 92014 ($256.8K, 7.0%). This level of concentration indicates business risk and opportunity tied to a few therapy and visit lines.

The procedure mix points to a high‑volume intravitreal injection/medical‑retina practice: J0178 reports 3K claims with an average paid/claim of $684 and is the single largest revenue driver at $2.1M, and 67028 appears as a common injectable procedure with 2.1K claims and $193.6K revenue. Those injection volumes, together with frequent established‑patient visits (92014, 2.9K claims), are consistent with ongoing, office‑based management of chronic retinal disease.

Imaging and documentation capacity is notable: 92134 (2.1K claims, $65.9K) ranks in the 96th percentile nationally and 92250 (1K claims, $27.8K) is an extreme outlier at the 99th percentile. High utilization of retinal imaging and fundus photography supports the clinical pattern of active retina diagnosis and monitoring in the office setting.

Competitive standing varies by code but shows clear national strength on several items: J0178 ranks #181 of 3204 providers (94th percentile) — described as notably above typical national volume — while 92014 ranks #76 of 35415 providers (100th percentile) and is labeled an extreme outlier, indicating unusually high national billing for comprehensive established exams. Other high‑volume codes such as 67028 (rank #361 of 4255, 92th percentile) also sit well above typical national volumes, underscoring a strong market presence in injectable eye care.

The provider also bills for a meaningful share of unclassified or specialty drug codes, which together represent nontrivial revenue: J3490 ($210.7K, 5.7%; rank #638 of 2838, 77th percentile) and J3590 ($175.9K, 4.8%; rank #339 of 631, 46th percentile) appear on the list. Presence of Q5128 ($136.7K, 3.7%) and J7999 ($9.3K, 0.3%) further indicates use of biosimilars and unclassified/compounded drug billing lines alongside branded injectable therapies.

Visit mix suggests a follow‑up‑heavy practice with some new‑patient activity: 92014 (established comprehensive exam) accounts for $256.8K and 2.9K claims, while 99204 (new patient, moderate complexity) appears with 176 claims and $20.8K revenue. This pattern aligns with managing an established patient panel that requires recurrent visits and discrete injection encounters.

The provider has a long tenure in the Medicare program, with NPI enumeration on 2005-05-27 (~21 years ago), which supports the likelihood of an established referral base and operational infrastructure capable of sustaining the high injection and imaging volumes observed. Long enrollment also suggests historical continuity rather than a recent, short‑term surge in activity.

Medicare: Complete Services Breakdown

The CPT/HCPCS codes generating the most Medicare revenue for this provider.

20 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
J0178	Injection, aflibercept, 1 mg	3,030	$680	$2.1M
J2778	Injection, ranibizumab, 0.1 mg	1,650	$190	$307.1K
92014	An ophthalmologist sees an established patient for a comprehensive level eye examination. Generally, a patient is considered to be "established" if the same physician, or any physician in the group…	2,850	$90	$256.8K
J3490	Unclassified drugs	120	$1,790	$210.7K
67028	The provider injects a medication into the vitreous chamber of the eye as an isolated procedure or a separate procedure unrelated to any other procedure being performed on the eye.	2,080	$90	$193.6K
J3590	Unclassified biologics	80	$2,290	$175.9K
Q5128	Injection, ranibizumab-eqrn (cimerli), biosimilar, 0.1 mg	640	$210	$136.7K
J2777	Injection, faricimab‑svoa, 0.1 mg	4,200	$30	$113.4K
J2781	Injection, pegcetacoplan, intravitreal, 1 mg	620	$120	$72K
92134	The provider performs computerized diagnostic imaging of the retina in the posterior segment (back part) of the eye, interprets the data, and provides a report. The service may be on one or both eyes.	2,060	$30	$65.9K

Showing 1–10 of 20

Medicare: Competitive Analysis & Benchmarks

How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 20 CPT/HCPCS codes.

View: State1 / 2

Claims Volume vs. Maryland Distribution

Matthew Speicher — 2 of 20 codes billed far more than typical (above p95)

p5–p95 (all providers)p25–p75MedianThis providerOutlier

Rank Distribution — Maryland

Full comparison — all codes billed, vs. state median

20 rows

CPT/HCPCS Code	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
J0178	11	100	950	$690	$887.3K
J2777	52	70	8,520	$30	$487.3K
J2781	9	20	620	$120	$258.6K
J2778	11	50	650	$180	$207.8K
J3590	7	20	50	$2,390	$128.9K
67028	23	120	700	$100	$101.5K
Q5128	3	20	200	$210	$78K
J3490	28	100	70	$450	$62.1K
92014	14	620	210	$90	$44K
92235	62	90	70	$110	$19.5K

Showing 1–10 of 20

Related Providers

Other providers that share a Tax Identification Number (TIN) with Matthew Speicher, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Associated Retinal Consultants LLC	DE	Ophthalmology Physician	$0	$25.2M
The Retina Group Of Washington, PLLC	MD	Ophthalmology Physician	$0	$19.5M
Virginia Oncology Associates	VA	Hematology & Oncology Physician	$0	$6.2M
Rohit Lakhanpal	MD	Retina Specialist (Ophthalmology) Physician	$6.1M	$0
Gordon Byrnes	VA	Retina Specialist (Ophthalmology) Physician	$4.9M	$0
Daniel Berinstein	MD	Retina Specialist (Ophthalmology) Physician	$4.3M	$0
Alexander Melamud	VA	Retina Specialist (Ophthalmology) Physician	$4.2M	$0
Michael Lai	MD	Retina Specialist (Ophthalmology) Physician	$4.2M	$0
Jordana Fein	VA	Retina Specialist (Ophthalmology) Physician	$4.2M	$0
Vinod Voleti	NJ	Retina Specialist (Ophthalmology) Physician	$4.1M	$0

Nearby Providers

Other providers in the same ZIP code as Matthew Speicher, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Neel S. Satpute, Dds, PA	MD	Dental Clinic/Center	$0	$5M
Newman Sund	MD	Ophthalmology Physician	$4M	$0
Eric Suan	MD	Ophthalmology Physician	$3.8M	$0
Timothy Polk	MD	Ophthalmology Physician	$3.5M	$0
Chaim Mond	MD	Rheumatology Physician	$1.7M	$418.1K
Heather Tamez	MD	Retina Specialist (Ophthalmology) Physician	$1.3M	$0
Greenspring Surgery Center LLC	MD	Ambulatory Surgical Clinic/Center	$1M	$1.8K
Jeffrey Banker	MD	Cardiovascular Disease Physician	$683.4K	$0
Sunal Makadia	MD	Cardiovascular Disease Physician	$433.2K	$0
Lisa Grant	MD	Pain Medicine (Physical Medicine & Rehabilitation) Physician	$343.5K	$0

Matthew Speicher — Billing Profile & Reimbursement Data

Sign up for Matthew Speicher — Billing Profile & Reimbursement Data policy alerts

Matthew Speicher — Billing Profile & Reimbursement Data

Sign up for Matthew Speicher — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicare: Total Revenue Breakdown by CPT/HCPCS Code

Medicare: Complete Services Breakdown

Medicare: Competitive Analysis & Benchmarks

Related Providers

Nearby Providers

Frequently Asked Questions

References